StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
48
This year
2
Publishing Date
2024 - 03 - 07
1
2024 - 03 - 05
1
2023 - 11 - 03
2
2023 - 10 - 23
2
2023 - 10 - 20
2
2023 - 10 - 16
1
2023 - 10 - 13
1
2023 - 09 - 26
1
2023 - 09 - 19
1
2023 - 08 - 14
1
2023 - 08 - 04
2
2023 - 06 - 05
1
2023 - 05 - 26
1
2023 - 05 - 25
1
2023 - 05 - 10
1
2023 - 05 - 05
1
2023 - 04 - 12
2
2023 - 03 - 24
1
2023 - 03 - 03
1
2023 - 02 - 21
1
2022 - 12 - 01
1
2022 - 11 - 14
1
2022 - 11 - 10
1
2022 - 11 - 07
1
2022 - 07 - 27
1
2022 - 04 - 08
1
2022 - 03 - 09
2
2022 - 01 - 24
1
2022 - 01 - 14
1
2021 - 12 - 15
1
2021 - 12 - 10
3
2021 - 11 - 03
1
2021 - 10 - 19
1
2021 - 10 - 14
1
2021 - 09 - 20
1
2021 - 08 - 06
1
2021 - 05 - 20
1
2021 - 03 - 10
1
2021 - 03 - 05
2
Sector
Consumer services
1
Health technology
48
Professional, scientific, and technical services
4
Tags
Alliances
2
America
1
Artificial intelligence
1
Asco
4
Award
1
Biocanada
21
Biomarkers
2
Biotech
85
Biotech-beach
2
Breast
6
Breast cancer
9
Cancer
41
Cancer drug
1
Cel
1
Ces
1
Chinese
3
Clinical-trials-phase-ii
4
Companies
1
Conference
19
Designation
1
Drug
1
Earnings
4
Ema
2
Enroll
1
Events
8
Fast track designation
2
Fda
5
Financial
12
Financial results
7
For
1
Gastrointestinal
4
Glioblastoma
1
Growth
3
Immunotherapy
2
Iot
31
Meeting
11
N/a
48
Negative
2
Pancreas
2
Pancreatic
14
People
2
Phase 1
6
Phase 2
2
Phase 2b
2
Positive
8
Potential
2
Pre-clinical
5
Preclinical
5
Presentation
9
Research
7
Response
3
Results
26
Study
4
Success
2
Symposium
5
Test
3
Therapy
6
Treatment
9
Trial
14
Year
5
Entities
Accuray incorporated
1
Amgen inc.
1
Astrazeneca plc
3
Athenex, inc.
1
Beigene, ltd.
1
Biontech se
3
Briacell therapeutics corp.
2
Bristol-myers squibb company
3
Clovis oncology, inc.
1
Cytomx therapeutics, inc.
1
Day one biopharmaceuticals inc
1
Eli lilly and company
2
Exact sciences corporation
1
Gilead sciences, inc.
1
Hologic, inc.
2
Illumina, inc.
1
Immunogen, inc.
2
Incyte corporation
2
Legend biotech corporation
1
Marker therapeutics, inc.
1
Merck & company, inc.
3
Merrimack pharmaceuticals, inc.
1
Merus n.v.
1
Mirati therapeutics, inc.
2
Myriad genetics, inc.
1
Nektar therapeutics
1
Novartis ag
1
Oncolytics biotech inc.
48
Pfizer, inc.
2
Pyxis oncology inc
1
Relay therapeutics, inc.
1
Sanofi
1
Seagen inc.
1
Seelos therapeutics, inc.
1
Symbols
AAPL
1191
ABB
1423
ABBV
783
ABLZF
1162
ABT
1561
ACN
600
AMGN
569
ARVL
4166
AVGO
582
BDX
690
BNPQF
1736
BNPQY
1736
CSCO
894
DELL
575
DHR
725
DOW
554
ERIC
1594
EXTR
581
F
636
FNCTF
6832
FRBA
594
GE
885
GLAXF
615
GOOG
1056
GOOGL
1056
GSK
788
HON
1778
HUBS
1400
IBM
651
INTC
946
IT
589
JNJ
2883
LLY
1119
LMT
575
LTUM
970
LYV
717
MDT
1147
MMM
926
MS
3850
MSFT
1191
MT
587
NOC
587
NOK
898
NOKBF
972
NVS
1115
NVSEF
945
ORCL
1154
PCRFF
650
PCRFY
650
PHG
956
PPRUF
1061
PPRUY
1062
SAP
1473
SAPGF
1228
SNOW
794
SNY
2815
SNYNF
2232
TMO
1408
VZ
1202
XYF
652
Exchanges
Nasdaq
48
Nyse
7
Crawled Date
2024 - 03 - 07
1
2024 - 03 - 05
1
2023 - 11 - 03
2
2023 - 10 - 23
2
2023 - 10 - 20
2
2023 - 10 - 16
1
2023 - 10 - 13
1
2023 - 09 - 26
1
2023 - 09 - 19
1
2023 - 08 - 14
1
2023 - 08 - 04
2
2023 - 06 - 05
1
2023 - 05 - 26
1
2023 - 05 - 25
1
2023 - 05 - 10
1
2023 - 05 - 05
1
2023 - 04 - 12
2
2023 - 03 - 24
1
2023 - 03 - 03
1
2023 - 02 - 21
1
2022 - 12 - 01
1
2022 - 11 - 14
1
2022 - 11 - 10
1
2022 - 11 - 07
1
2022 - 07 - 27
1
2022 - 04 - 08
1
2022 - 03 - 09
2
2022 - 01 - 24
1
2022 - 01 - 14
1
2021 - 12 - 15
1
2021 - 12 - 10
3
2021 - 11 - 03
1
2021 - 10 - 19
1
2021 - 10 - 14
1
2021 - 09 - 20
1
2021 - 08 - 06
1
2021 - 05 - 20
1
2021 - 03 - 10
1
2021 - 03 - 05
2
Crawled Time
11:00
15
12:00
3
12:20
2
12:30
2
13:00
6
13:11
2
13:20
2
14:00
2
14:20
1
14:30
1
15:00
1
16:00
2
17:00
4
18:00
1
19:00
1
21:00
1
22:00
1
22:04
1
Source
www.prnewswire.com
48
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
N::A
symbols :
ONCY
save search
Oncolytics Biotech® Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
Published:
2024-03-07
(Crawled : 21:00)
- prnewswire.com
ONCY
|
$1.045
-3.24%
-3.35%
180K
|
Health Technology
|
5.77%
|
O:
2.88%
H:
4.67%
C:
-1.87%
biotech
year
financial
results
Oncolytics Biotech® Files Amendment to Initiate New Pancreatic Cancer GOBLET Cohort Supported by PanCAN
Published:
2024-03-05
(Crawled : 12:00)
- prnewswire.com
ONCY
|
$1.045
-3.24%
-3.35%
180K
|
Health Technology
|
19.57%
|
O:
6.52%
H:
6.12%
C:
5.1%
biotech
cancer
pancreatic
Oncolytics Biotech® and SOLTI Present Further Positive Pelareorep Translational Data at SITC
Published:
2023-11-03
(Crawled : 16:00)
- prnewswire.com
ONCY
|
$1.045
-3.24%
-3.35%
180K
|
Health Technology
|
-38.55%
|
O:
0.0%
H:
0.56%
C:
-3.91%
biotech
positive
Oncolytics Biotech® Reports Third Quarter 2023 Financial Results and Operational Highlights
Published:
2023-11-03
(Crawled : 11:00)
- prnewswire.com
ONCY
|
$1.045
-3.24%
-3.35%
180K
|
Health Technology
|
-38.55%
|
O:
0.0%
H:
0.56%
C:
-3.91%
biotech
financial
results
Oncolytics Achieves Success Criteria for Efficacy in the Third-Line Colorectal Cancer Cohort of the GOBLET Study
Published:
2023-10-23
(Crawled : 11:00)
- prnewswire.com
ONCY
|
$1.045
-3.24%
-3.35%
180K
|
Health Technology
|
-29.03%
|
O:
0.65%
H:
9.94%
C:
8.33%
success
cancer
study
Oncolytics Presents Positive Updated Pancreatic Cancer Data from GOBLET Phase 1/2 Study at ESMO
Published:
2023-10-23
(Crawled : 11:00)
- prnewswire.com
ONCY
|
$1.045
-3.24%
-3.35%
180K
|
Health Technology
|
-29.03%
|
O:
0.65%
H:
9.94%
C:
8.33%
positive
cancer
pancreatic
study
Biotech Companies Make Further Progress in Promising Pancreatic Cancer Treatment Research
Published:
2023-10-20
(Crawled : 14:30)
- prnewswire.com
SGEN
|
$228.74
0.1%
20M
|
Health Technology
|
6.41%
|
O:
0.15%
H:
0.0%
C:
0.0%
ONCY
|
$1.045
-3.24%
-3.35%
180K
|
Health Technology
|
-32.1%
|
O:
-1.85%
H:
3.14%
C:
-2.52%
MYGN
|
News
F
|
$18.66
-1.37%
-1.39%
550K
|
Health Technology
|
29.06%
|
O:
0.41%
H:
3.13%
C:
2.38%
ILMN
|
$118.305
0.52%
0.52%
1.9M
|
Health Technology
|
-1.91%
|
O:
0.02%
H:
0.94%
C:
-0.3%
BNTX
|
$86.42
0.09%
0.09%
1.2M
|
Health Technology
|
-7.4%
|
O:
-1.46%
H:
0.48%
C:
-1.06%
companies
biotech
cancer
pancreatic
treatment
research
Oncolytics Biotech® to Host Conference Call to Discuss Third Quarter Financial Results and Recent Operational Highlights
Published:
2023-10-20
(Crawled : 11:00)
- prnewswire.com
ONCY
|
$1.045
-3.24%
-3.35%
180K
|
Health Technology
|
-32.1%
|
O:
-1.85%
H:
3.14%
C:
-2.52%
biotech
conference
financial
results
Oncolytics Biotech® To Present Two Posters on the Pelareorep-Based GOBLET Study at ESMO 2023
Published:
2023-10-16
(Crawled : 11:00)
- prnewswire.com
ONCY
|
$1.045
-3.24%
-3.35%
180K
|
Health Technology
|
-40.86%
|
O:
1.61%
H:
1.59%
C:
-3.17%
biotech
study
New FDA Designations Accelerate Progress in Pancreatic Cancer Treatments: A Year in Review
Published:
2023-10-13
(Crawled : 13:00)
- prnewswire.com
PYXS
|
$4.845
3.31%
3.2%
570K
|
Professional, Scientific, and T...
|
140.51%
|
O:
0.0%
H:
2.56%
C:
2.56%
LLY
|
News
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
22.71%
|
O:
1.15%
H:
0.0%
C:
0.0%
ONCY
|
$1.045
-3.24%
-3.35%
180K
|
Health Technology
|
-40.22%
|
O:
-1.63%
H:
4.97%
C:
2.76%
MRUS
|
$41.01
1.74%
1.71%
410K
|
Health Technology
|
91.22%
|
O:
0.47%
H:
1.7%
C:
-0.38%
AZN
|
$68.53
0.39%
0.39%
3.7M
|
Health Technology
|
0.23%
|
O:
-0.59%
H:
0.62%
C:
-0.56%
fda
year
review
cancer
pancreatic
THE PANCREATIC CANCER ACTION NETWORK SELECTS ONCOLYTICS BIOTECH® INC. TO RECEIVE $5 MILLION THERAPEUTIC ACCELERATOR AWARD TO DEVELOP LEADING-EDGE TREATMENTS
Published:
2023-09-26
(Crawled : 11:00)
- prnewswire.com
ONCY
|
$1.045
-3.24%
-3.35%
180K
|
Health Technology
|
-48.36%
|
O:
0.0%
H:
5.63%
C:
4.69%
biotech
award
cancer
pancreatic
network
Pancreatic Cancer Battle Boosted by $200M VC Firm
Published:
2023-09-19
(Crawled : 17:00)
- prnewswire.com
ONCY
|
$1.045
-3.24%
-3.35%
180K
|
Health Technology
|
-46.08%
|
O:
-1.47%
H:
4.98%
C:
3.98%
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
84.91%
|
O:
-0.13%
H:
2.0%
C:
1.83%
MACK
4
|
$14.68
0.0%
100K
|
Health Technology
|
19.93%
|
O:
-0.41%
H:
0.9%
C:
0.74%
INCY
|
$52.74
-0.9%
-0.91%
2.5M
|
Health Technology
|
-10.57%
|
O:
0.03%
H:
2.18%
C:
1.8%
BNTX
|
$86.42
0.09%
0.09%
1.2M
|
Health Technology
|
-20.82%
|
O:
-0.01%
H:
1.99%
C:
1.28%
cancer
pancreatic
Oncolytics Biotech® Reports Second Quarter 2023 Financial Results and Operational Highlights
Published:
2023-08-14
(Crawled : 11:00)
- prnewswire.com
ONCY
|
$1.045
-3.24%
-3.35%
180K
|
Health Technology
|
-49.54%
|
O:
-3.67%
H:
0.95%
C:
-2.38%
biotech
financial
results
Oncolytics Biotech® to Host Conference Call to Discuss Second Quarter Financial Results and Recent Operational Highlights
Published:
2023-08-04
(Crawled : 11:00)
- prnewswire.com
ONCY
|
$1.045
-3.24%
-3.35%
180K
|
Health Technology
|
-52.89%
|
O:
-4.93%
H:
0.0%
C:
0.0%
biotech
conference
financial
results
Oncolytics Biotech® to Participate in a Fireside Chat at Canaccord Genuity's 43rd Annual Growth Conference
Published:
2023-08-04
(Crawled : 11:00)
- prnewswire.com
ONCY
|
$1.045
-3.24%
-3.35%
180K
|
Health Technology
|
-52.89%
|
O:
-4.93%
H:
0.0%
C:
0.0%
biotech
conference
growth
Oncolytics Biotech® Announces Updated Randomized Phase 2 Data from BRACELET-1 Metastatic Breast Cancer Trial that Show Pelareorep Driving Robust Increases in Progression-Free Survival and Confirmed Overall Response Rate
Published:
2023-06-05
(Crawled : 11:00)
- prnewswire.com
ONCY
|
$1.045
-3.24%
-3.35%
180K
|
Health Technology
|
-36.05%
|
O:
-1.74%
H:
2.96%
C:
-2.96%
biotech
breast
cancer
trial
response
show
Promising Developments Announced Ahead of 2023 ASCO Annual Meeting's Oral Presentations
Published:
2023-05-26
(Crawled : 15:00)
- prnewswire.com
DAWN
4
|
$14.87
1.78%
1.75%
800K
|
Professional, Scientific, and T...
|
21.14%
|
O:
0.33%
H:
4.21%
C:
3.06%
ONCY
|
$1.045
-3.24%
-3.35%
180K
|
Health Technology
|
-49.07%
|
O:
-0.93%
H:
0.0%
C:
-18.22%
LEGN
|
$48.84
-2.55%
-2.62%
1.4M
|
Health Technology
|
-20.8%
|
O:
0.35%
H:
0.63%
C:
-0.58%
IMGN
|
$31.23
0.03%
49M
|
Health Technology
|
126.05%
|
O:
0.07%
H:
2.53%
C:
1.23%
GILD
|
$66.94
-0.55%
-0.55%
5.3M
|
Health Technology
|
-13.32%
|
O:
0.45%
H:
0.79%
C:
-1.17%
asco
Oncolytics Biotech® Announces Positive Randomized Phase 2 Data from BRACELET-1 Metastatic Breast Cancer Trial Demonstrating Pelareorep Drives ≥50% Improvements in ORR and mPFS in an ASCO Annual Meeting Abstract
Published:
2023-05-25
(Crawled : 22:00)
- prnewswire.com
ONCY
|
$1.045
-3.24%
-3.35%
180K
|
Health Technology
|
-49.07%
|
O:
-0.93%
H:
0.0%
C:
-18.22%
biotech
breast
asco
positive
cancer
meeting
trial
Oncolytics Biotech® Announces Voting Results from the Annual General Meeting of Shareholders
Published:
2023-05-10
(Crawled : 11:00)
- prnewswire.com
ONCY
|
$1.045
-3.24%
-3.35%
180K
|
Health Technology
|
-32.52%
|
O:
0.0%
H:
1.84%
C:
0.0%
biotech
meeting
results
Oncolytics Biotech® Reports First Quarter 2023 Financial Results and Operational Highlights
Published:
2023-05-05
(Crawled : 11:00)
- prnewswire.com
ONCY
|
$1.045
-3.24%
-3.35%
180K
|
Health Technology
|
-24.14%
|
O:
-0.69%
H:
13.19%
C:
11.11%
biotech
financial
results
← Previous
1
2
3
Next →
Gainers vs Losers
56%
44%
Top 10 Gainers
INVO
|
$1.76
131.58%
56.82%
230M
|
Health Technology
SINT
|
$0.0365
59.39%
37.26%
470M
|
Health Technology
WISA
4
|
$9.19
50.66%
33.7%
65M
|
Electronic Technology
EDBL
|
News
|
$6.73
47.91%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
640K
|
Manufacturing
TCON
|
$2.33
36.26%
26.61%
2M
|
Health Technology
TIRX
|
$0.48
6.43%
24.58%
4.8M
|
KZIA
|
$0.38
30.58%
23.42%
300K
|
Health Technology
VNDA
|
News
|
$5.23
29.14%
22.56%
24M
|
Health Technology
ATNF
|
$1.91
29.05%
22.51%
310K
|
Your saved searches
Save your searches and get alerts when important news are released.